Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand

201711 citationsJournal Articlebronze Open Access

Authors

Intira Jeannie Collins · MRC Clinical Trials Unit at UCL

Luminiţa Ene

Antoni Noguera‐Julián

Sara Guillén

Pablo Rojo Conejo

Abstract

One in 5 children switched to a second-line regimen by 5 years of ART, with two-thirds failure related. Advanced HIV, older age, and NVP-based regimens were associated with increased risk of switch.

Topics & Keywords

HIV/AIDS drug development and treatment HIV/AIDS Research and Interventions HIV Research and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Infectious Diseases

Volume 66, Issue 4, pp. 594-603

DOI: 10.1093/cid/cix854

Field-Weighted Citation Impact: 0.63